Observational studyCancer reports (Hoboken, N.J.)2026

Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study.

Takashi Kawahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.